DK2310017T3 - Nifurtimox til behandling af sygdomme fremkaldt af trichomonadida - Google Patents

Nifurtimox til behandling af sygdomme fremkaldt af trichomonadida

Info

Publication number
DK2310017T3
DK2310017T3 DK09772098.1T DK09772098T DK2310017T3 DK 2310017 T3 DK2310017 T3 DK 2310017T3 DK 09772098 T DK09772098 T DK 09772098T DK 2310017 T3 DK2310017 T3 DK 2310017T3
Authority
DK
Denmark
Prior art keywords
trichomonadida
nifurtimox
treatment
induced diseases
diseases
Prior art date
Application number
DK09772098.1T
Other languages
English (en)
Inventor
Achim Harder
Gisela Greif
Robrecht Froyman
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Application granted granted Critical
Publication of DK2310017T3 publication Critical patent/DK2310017T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fodder In General (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK09772098.1T 2008-07-02 2009-06-20 Nifurtimox til behandling af sygdomme fremkaldt af trichomonadida DK2310017T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102008031283A DE102008031283A1 (de) 2008-07-02 2008-07-02 Neue Bekämpfungsmöglichkeit von durch Trichomonadida hervorgerufenen Krankheiten
PCT/EP2009/004474 WO2010000398A1 (de) 2008-07-02 2009-06-20 Nifurtimox zur behandlung von durch trichomonadida hervorgerufenen krankheiten

Publications (1)

Publication Number Publication Date
DK2310017T3 true DK2310017T3 (da) 2013-07-01

Family

ID=41092164

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09772098.1T DK2310017T3 (da) 2008-07-02 2009-06-20 Nifurtimox til behandling af sygdomme fremkaldt af trichomonadida

Country Status (26)

Country Link
US (1) US8440613B2 (da)
EP (1) EP2310017B1 (da)
JP (1) JP5571659B2 (da)
KR (1) KR20110031360A (da)
CN (1) CN102083440B (da)
AR (1) AR072426A1 (da)
AU (1) AU2009266124B2 (da)
CA (1) CA2729727A1 (da)
CL (1) CL2010001594A1 (da)
CO (1) CO6321268A2 (da)
CR (1) CR20110023A (da)
DE (1) DE102008031283A1 (da)
DK (1) DK2310017T3 (da)
DO (1) DOP2010000406A (da)
EC (1) ECSP10010721A (da)
ES (1) ES2415231T3 (da)
IL (1) IL209999A0 (da)
MX (1) MX2010014444A (da)
NI (1) NI201100009A (da)
PE (1) PE20110370A1 (da)
PL (1) PL2310017T3 (da)
RU (1) RU2538712C2 (da)
SV (1) SV2011003784A (da)
UA (1) UA103197C2 (da)
WO (1) WO2010000398A1 (da)
ZA (1) ZA201009226B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2633855A1 (en) * 2012-03-01 2013-09-04 Veterinärmedizinische Universität Wien Protease inhibitors for treating Trichomonas gallinae infections
CN107835818B (zh) 2015-05-20 2022-04-29 勃林格殷格翰动物保健美国公司 驱虫缩酚酸肽化合物
KR20220003663A (ko) 2015-12-28 2022-01-10 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 구충성 뎁시펩티드 화합물
JP6085706B1 (ja) * 2016-03-31 2017-02-22 株式会社ポーラファルマ 抗トリトリコモナス剤
EP3541789A1 (en) 2016-11-16 2019-09-25 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1170957B (de) 1962-11-23 1964-05-27 Bayer Ag Verfahren zur Herstellung von 5-Nitro-furfuryliden-(2)-iminoderivaten
NO176766C (no) * 1989-02-07 1995-05-24 Meiji Seika Kaisha Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet
CA2132199C (en) 1992-03-17 2000-01-18 Hitoshi Nishiyama Depsipeptide derivative, production thereof and use thereof
DE4317458A1 (de) * 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
CN1073560C (zh) 1993-02-19 2001-10-24 明治制果株式会社 环缩酚酸肽pf1022衍生物
DE4317457A1 (de) 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317432A1 (de) 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
US5646244A (en) 1993-09-06 1997-07-08 Fujisawa Pharmaceutical Co., Ltd. Cyclodepsipeptide compound
DE4401389A1 (de) 1994-01-19 1995-07-20 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 12 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 12 Ringatomen und Verfahren zu ihrer Herstellung
DE4406025A1 (de) 1994-02-24 1995-08-31 Bayer Ag Milchsäure-haltige cyclische Depsipeptide mit 18 Ringatomen als endoparasitizide Mittel und Verfahren zu ihrer Herstellung
DE4437198A1 (de) 1994-10-18 1996-04-25 Bayer Ag Verfahren zur Sulfonylierung, Sulfenylierung und Phosphorylierung von cyclischen Depsipeptiden
CN1071323C (zh) * 1995-06-30 2001-09-19 藤泽药品工业株式会社 缩肽衍生物或其盐的制造方法
NZ318515A (en) 1995-09-22 2000-05-26 Bayer Ag Cyclodepsipeptide PF1022 derivatives and compositions thereof
DE19545639A1 (de) 1995-12-07 1997-06-12 Bayer Ag Verfahren zur Herstellung von substituierten Arylmilchsäure-haltigen Cyclodepsipeptiden mit 24 Ringatomen
US6503881B2 (en) * 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
UA5478U (uk) * 2004-06-21 2005-03-15 Ігор Едуардович Лук'янов Спосіб лікування хворих на урогенітальний трихомоніаз
ZA200704784B (en) * 2004-11-12 2008-10-29 Celgene Corp Methods and compositions using immunomodulatory compounds for treatment and management of parasitic diseases

Also Published As

Publication number Publication date
EP2310017B1 (de) 2013-05-15
ES2415231T3 (es) 2013-07-24
AU2009266124A1 (en) 2010-01-07
MX2010014444A (es) 2011-02-22
DE102008031283A1 (de) 2010-01-07
ECSP10010721A (es) 2011-01-31
ZA201009226B (en) 2012-03-23
JP2011526264A (ja) 2011-10-06
US20110118176A1 (en) 2011-05-19
US8440613B2 (en) 2013-05-14
JP5571659B2 (ja) 2014-08-13
CO6321268A2 (es) 2011-09-20
KR20110031360A (ko) 2011-03-25
RU2011103476A (ru) 2012-08-10
AR072426A1 (es) 2010-08-25
CN102083440A (zh) 2011-06-01
DOP2010000406A (es) 2011-01-15
PL2310017T3 (pl) 2013-08-30
EP2310017A1 (de) 2011-04-20
CA2729727A1 (en) 2010-01-07
AU2009266124B2 (en) 2015-03-19
PE20110370A1 (es) 2011-06-22
RU2538712C2 (ru) 2015-01-10
SV2011003784A (es) 2011-05-20
WO2010000398A1 (de) 2010-01-07
CR20110023A (es) 2011-05-10
IL209999A0 (en) 2011-02-28
UA103197C2 (uk) 2013-09-25
CL2010001594A1 (es) 2011-05-06
NI201100009A (es) 2011-08-10
CN102083440B (zh) 2013-03-27

Similar Documents

Publication Publication Date Title
DK2504005T3 (da) Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme
DK1874781T3 (da) Dihydrothienopyrimidiner til behandling af inflammatoriske sygdomme
DK3192520T3 (da) Terapeutiske midler til reducering af niveauerne af parathyreoideahormon
DK3456707T3 (da) 4-(p-quinonyl)-2-hydroxybutanamidderivater til behandling af mitokondriesygdomme
DK2498771T3 (da) Anvendelse af bethanechol til behandling af xerostomi
DK3289876T3 (da) Forbindelser til behandling af cancer
DK2474321T3 (da) Sammensætninger til behandling af collagenmedierede sygdomme
DK2451482T3 (da) Kombinationsterapi til behandlingen af diabetes
DK2285808T3 (da) Spiroindolderivater til behandling af parasitsygdomme
SMAP200900085A (it) 3-imidazolil-indoli per il trattamento di malattieproliferative
DK2056842T3 (da) Modificeret galactosylceramid til behandling af cancerøse sygdomme
DK2381965T3 (da) Modulation af præ-mrna under anvendelse af splejsningsmodulerende oligonukleotider som terapeutiske midler til behandling af sygdom
PL3354276T3 (pl) Kompozycje do leczenia zapalenia przewodu pokarmowego
DK3400944T3 (da) Ibat-inhibitorer til behandling af leversygdomme
DK2620493T3 (da) Mesenkymale stamceller til behandling af CNS-sygdomme
DK2500047T3 (da) Lægemiddelfrigivende coatinger til medicinske indretninger
PL2338519T3 (pl) Środek do leczenia zwłóknienia szpiku
DK2440230T3 (da) Behandlingsregimener til behandling af neurologisk sygdom
DK2117525T3 (da) Anvendelse af 1-phenyl-3-dimethylamino-propanforbindelser til behandling af neuropatismerte
DK2627345T3 (da) Formuleringer til behandling af sygdomme i de øvre luftveje
DK2209784T3 (da) Forbindelser til behandling af hepatitis C
DK2117565T3 (da) Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme
DK2382232T3 (da) Fremgangsmåde til fremstilling af bivalirudin
DK2164572T3 (da) Carbamoyl-cyclohexaner til behandling af akut mani
DK2554171T3 (da) Fremgangsmåde til behandling af sygdomme